Author:
Yang Jing,Zhang Rui,Han Bing,Li Hui,Wang Jingfeng,Xiao Yihui,Yu Xiaofan,Guan Shaofeng,Dai Cuilian,Yan Hua,Jiang Tingbo,Cui Hanbin,Yang Shuang,Zheng Zeqi,Dong Yugang,Wang Annai,Su Guohai,Wang Yan
Funder
the National Key Research and Development Program of China
Xuhui Healthcare System Peak Discipline Construction Funding Project
Publisher
Springer Science and Business Media LLC
Reference47 articles.
1. Piironen M, Ukkola O, Huikuri H, Havulinna AS, Koukkunen H, Mustonen J, et al. Trends in long-term prognosis after acute coronary syndrome. Eur J Prev Cardiol. 2017;24(3):274–80.
2. Li L, Zhou X, Jin Z, Sun AG, Wang P. Z, Clinical characteristics and in-hospital management strategies in patients with acute coronary syndrome: results from 2,096 accredited chest Pain centers in China from 2016 to 2021. Cardiol Plus. 2022;7(4).
3. Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. 2023 ESC guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(38):3720–826.
4. Schwartz GG, Szarek M, Bhatt DL, Bittner VA, Bujas-Bobanovic M, Diaz R, et al. Transiently achieved very low LDL-cholesterol levels by statin and alirocumab after acute coronary syndrome are associated with cardiovascular risk reduction: the ODYSSEY OUTCOMES trial. Eur Heart J. 2023;44(16):1408–17.
5. Gaba P, O’Donoghue ML, Park JG, Wiviott SD, Atar D, Kuder JF, et al. Association between Achieved Low-Density Lipoprotein Cholesterol Levels and Long-Term Cardiovascular and Safety outcomes: an analysis of FOURIER-OLE. Circulation. 2023;147(16):1192–203.